HAEMATO AG NPV (POST SPLIT)HAEMATO AG NPV (POST SPLIT)HAEMATO AG NPV (POST SPLIT)

HAEMATO AG NPV (POST SPLIT)

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪88.58 M‬EUR
‪8.19 M‬EUR
‪248.14 M‬EUR
‪1.65 M‬
Beta (1Y)
0.28

About HAEMATO AG INH O.N.

CEO
Patrick Brenske
Headquarters
Schönefeld
Website
Founded
1993
ISIN
DE000A289VV1
FIGI
BBG00JVXH5Z3
Haemato AG engages in the pharmaceutical industry. It focuses on growth markets of patent-free, and patented medicinal products in the insurance-financed market. Its portfolio include therapies for cancer, HIV, rheumatology, and other chronic diseases, and products for the privately financed market for aesthetic treatments. It operates through the Lifestyle and Aesthetics, and Specially Pharma segments. The company was founded on May 10, 1993 and is headquartered in Schönefeld, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0VZ7 is 15.00 EUR — it has decreased by 46.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HAEMATO AG NPV (POST SPLIT) stocks are traded under the ticker 0VZ7.
HAEMATO AG NPV (POST SPLIT) is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
0VZ7 stock is 86.82% volatile and has beta coefficient of 0.28. Check out the list of the most volatile stocks — is HAEMATO AG NPV (POST SPLIT) there?
HAEMATO AG NPV (POST SPLIT) revenue for the last quarter amounts to ‪151.53 M‬ EUR despite the estimated figure of ‪151.50 M‬ EUR. In the next quarter revenue is expected to reach ‪121.00 M‬ EUR.
Yes, you can track HAEMATO AG NPV (POST SPLIT) financials in yearly and quarterly reports right on TradingView.
Today HAEMATO AG NPV (POST SPLIT) has the market capitalization of ‪88.58 M‬, it has decreased by 3.80% over the last week.
Yes, 0VZ7 dividends are paid annually. The last dividend per share was 1.20 EUR. As of today, Dividend Yield (TTM)% is 7.06%. Tracking HAEMATO AG NPV (POST SPLIT) dividends might help you take more informed decisions.
HAEMATO AG NPV (POST SPLIT) dividend yield was 6.98% in 2022, and payout ratio reached 76.32%. The year before the numbers were 4.60% and 87.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0VZ7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HAEMATO AG NPV (POST SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
0VZ7 reached its all-time high on Mar 22, 2018 with the price of 61.20 EUR, and its all-time low was 15.00 EUR and was reached on Apr 10, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HAEMATO AG NPV (POST SPLIT) technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HAEMATO AG NPV (POST SPLIT) stock shows the strong sell signal. See more of HAEMATO AG NPV (POST SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.